TROPION-Breast02: Phase 3, Open-Label, Randomized Study of First-Line Datopotamab Deruxtecan Versus Chemotherapy in Patients with Locally Recurrent Inoperable or Metastatic TNBC Who Are Not Candidates for Anti-Pd-(l)1 Therapy
CANCER RESEARCH（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined